Lipoprotein and HDL Function Core

脂蛋白和HDL功能核心

基本信息

  • 批准号:
    10089337
  • 负责人:
  • 金额:
    $ 23.76万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-06-01 至 2025-12-31
  • 项目状态:
    未结题

项目摘要

Summary Anti-atherogenic functions of HDL are likely due to its mediation of reverse cholesterol transport and to its anti-oxidative and anti-inflammatory effects. Mounting evidence supports the concept that HDL may become dysfunctional and that this contributes to the development of atherosclerosis. The goal of our research is to define the mechanisms for HDL dysfunction in diseases associated with significantly increased risk of atherosclerotic cardiovascular disease, including familial hypercholesterolemia, chronic kidney disease and rheumatoid arthritis. A major hypothesis of our proposal is that excessive inflammatory and oxidative burden impair HDL atheroprotective functions, including cholesterol efflux capacity and anti-inflammatory and anti- oxidative effects. Core B will be an integral part of the PPG by providing both analytical services for analysis and isolation of lipoproteins and in vitro assays of HDL function in macrophages. The goal of Specific Aim 1 is to provide isolation and analysis of lipoproteins, HDL subfractions, and apoproteins. The Lipoprotein and HDL Function Core (Core B) will assist investigators by isolating lipoproteins and apoproteins, including apoAI and apoAII, for functional studies and analyses of protein modifications. The goal of Specific Aim 2 is to provide assays for HDL functions, including the promotion of cholesterol efflux and efferocytosis in macrophages and the control of inflammation and oxidation. Core B provides a number of services to investigators that require unique instrumentation and methodologies and demand rigorous standardization procedures. It would be costly, inefficient, and cumbersome to establish these procedures in individual investigator laboratories. The consolidation of these services into the Core B laboratory provides investigators with efficient, high quality, low-cost analyses. Another objective of Core B is to provide education and training to investigators, fellows, and research technicians on the science and methods of lipoprotein preparation and studies of HDL function.
总结

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MACRAE F LINTON其他文献

MACRAE F LINTON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MACRAE F LINTON', 18)}}的其他基金

Macrophage SR-BI Regulates Autophagy, Angiogenin and tRNA-derived small RNAs
巨噬细胞 SR-BI 调节自噬、血管生成素和 tRNA 衍生的小 RNA
  • 批准号:
    9195133
  • 财政年份:
    2016
  • 资助金额:
    $ 23.76万
  • 项目类别:
Macrophage SR-BI Regulates Autophagy, Angiogenin and tRNA-derived small RNAs
巨噬细胞 SR-BI 调节自噬、血管生成素和 tRNA 衍生的小 RNA
  • 批准号:
    9029105
  • 财政年份:
    2016
  • 资助金额:
    $ 23.76万
  • 项目类别:
Dicarbonyl Scavengers to Improve HDL Function and Reduce Atherosclerosis in FH
二羰基清除剂可改善 FH 中的 HDL 功能并减少动脉粥样硬化
  • 批准号:
    10327715
  • 财政年份:
    2014
  • 资助金额:
    $ 23.76万
  • 项目类别:
HDL Function in Human Disease
HDL 在人类疾病中的功能
  • 批准号:
    10544047
  • 财政年份:
    2014
  • 资助金额:
    $ 23.76万
  • 项目类别:
Administration and Biostatistics Core
行政和生物统计学核心
  • 批准号:
    10089336
  • 财政年份:
    2014
  • 资助金额:
    $ 23.76万
  • 项目类别:
HDL Function in Human Disease
HDL 在人类疾病中的功能
  • 批准号:
    10089335
  • 财政年份:
    2014
  • 资助金额:
    $ 23.76万
  • 项目类别:
HDL Function in Human Disease
HDL 在人类疾病中的功能
  • 批准号:
    8852692
  • 财政年份:
    2014
  • 资助金额:
    $ 23.76万
  • 项目类别:
Lipoprotein and HDL Function Core
脂蛋白和HDL功能核心
  • 批准号:
    10544050
  • 财政年份:
    2014
  • 资助金额:
    $ 23.76万
  • 项目类别:
Administration and Biostatistics Core
行政和生物统计学核心
  • 批准号:
    10327711
  • 财政年份:
    2014
  • 资助金额:
    $ 23.76万
  • 项目类别:
Dicarbonyl Scavengers to Improve HDL Function and Reduce Atherosclerosis in FH
二羰基清除剂可改善 FH 中的 HDL 功能并减少动脉粥样硬化
  • 批准号:
    10089340
  • 财政年份:
    2014
  • 资助金额:
    $ 23.76万
  • 项目类别:

相似海外基金

Antiatherogenic effects of neutrophil alpha defensins
中性粒细胞α防御素的抗动脉粥样硬化作用
  • 批准号:
    8360808
  • 财政年份:
    2012
  • 资助金额:
    $ 23.76万
  • 项目类别:
Antiatherogenic effects of neutrophil alpha defensins
中性粒细胞α防御素的抗动脉粥样硬化作用
  • 批准号:
    8505376
  • 财政年份:
    2012
  • 资助金额:
    $ 23.76万
  • 项目类别:
Antiatherogenic effects of high density lipoprotein and sphingosine 1-phosphate
高密度脂蛋白和1-磷酸鞘氨醇的抗动脉粥样硬化作用
  • 批准号:
    18590973
  • 财政年份:
    2006
  • 资助金额:
    $ 23.76万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analysis of the mechanisms for antiatherogenic effect of bone marrow AT2 receptor by using gene-targeted mice
基因靶向小鼠分析骨髓AT2受体抗动脉粥样硬化作用机制
  • 批准号:
    17590760
  • 财政年份:
    2005
  • 资助金额:
    $ 23.76万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Antiatherogenic Properties of tert-Butylhydroquinone
叔丁基氢醌的抗动脉粥样硬化特性
  • 批准号:
    6786512
  • 财政年份:
    2004
  • 资助金额:
    $ 23.76万
  • 项目类别:
Antiatherogenic action of estrogen through inhibition of pathological proliferation in vascular smooth muscle sells
雌激素通过抑制血管平滑肌病理性增殖发挥抗动脉粥样硬化作用
  • 批准号:
    14370523
  • 财政年份:
    2002
  • 资助金额:
    $ 23.76万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
ANTIATHEROGENIC EFFECTS OF MODERATE ALCOHOL USE
适量饮酒的抗动脉粥样硬化作用
  • 批准号:
    6115236
  • 财政年份:
    1998
  • 资助金额:
    $ 23.76万
  • 项目类别:
ANTIATHEROGENIC EFFECTS OF MODERATE ALCOHOL USE
适量饮酒的抗动脉粥样硬化作用
  • 批准号:
    6276470
  • 财政年份:
    1997
  • 资助金额:
    $ 23.76万
  • 项目类别:
ANTIATHEROGENIC EFFECTS OF MODERATE ALCOHOL USE
适量饮酒的抗动脉粥样硬化作用
  • 批准号:
    6168341
  • 财政年份:
    1996
  • 资助金额:
    $ 23.76万
  • 项目类别:
ANTIATHEROGENIC EFFECTS OF MODERATE ALCOHOL USE
适量饮酒的抗动脉粥样硬化作用
  • 批准号:
    2769196
  • 财政年份:
    1996
  • 资助金额:
    $ 23.76万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了